About Rose PharmaRose Pharma is a clinical phase biopharmaceutical company focusing on development of novel treatments for irritable bowel syndrome (IBS) and functional dyspepsia (FD), disorders which affect 10-20% of the general population and which are large unmet clinical needs. The platform technology is based around glucagon-like peptide-1 (GLP-1). |
|
|
